1-20 of 36
Surbhi Sidana, MD
Close
Sort by
Journal Articles

Universal: An Allogeneic First-in-Human Study of the Anti-Bcma ALLO-715 and the Anti-CD52 ALLO-647 in Relapsed/Refractory Multiple Myeloma

Sham Mailankody, MBBS, Jeffrey V. Matous, MD, Michaela Liedtke, MD, Surbhi Sidana, MD, Shahbaz Malik, MD, Rajneesh Nath, MD, Olalekan O. Oluwole, MBBS, MPH, Erin E. Karski, Wade Lovelace, Xiangdong Zhou, PhD, Srinand Nandakumar, PhD, Arun Balakumaran, MD PhD, Parameswaran Hari, MD MRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-140641
Published: 2020
Journal Articles

Monitoring Measurable Residual Disease Using Peripheral Blood in Acute Lymphoblastic Leukemia: Results of a Prospective, Observational Study

Lori S. Muffly, MD MS, Vandana Sundaram, MPH, Connie Chen, Ilana Yurkiewicz, MD BS, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, MDFRCPC, Kelly Chyan, Sally Arai, MD MS, Matthew J. Frank, MD PhD, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Everett H Meyer, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Surbhi Sidana, MD, Parveen Shiraz, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Michaela Liedtke, MD, Hyma T. Vempaty, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-138988
Published: 2020
Journal Articles

Survival Following Post-HCT Relapse in Adult Acute Lymphoblastic Leukemia Has Improved in the Era of Novel Immunotherapies: A Single Institution Analysis

Juliana Craig, BA, Maria Iglesias, BS, Kristen Cunanan, PhD, Sally Arai, MD MS, Matthew J. Frank, MD PhD, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Everett H Meyer, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A Shizuru, MD PhD, Surbhi Sidana, MD, W-K Weng, MD PhD, Parveen Shiraz, MD, Lori S. Muffly, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-141489
Published: 2020
Journal Articles

Response Evaluation Using PET/CT in Multiple Myeloma Patients Undergoing Autologous Transplant

Tim Ellis-Caleo, MD, Surbhi Sidana, MD, Michaela Liedtke, MD, David Iberri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-143436
Published: 2020
Journal Articles

Maintenance Use Is More Important Than the Choice of Bortezomib-Based Triplet Induction in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplantation

Surbhi Sidana, MD, Shaji K. Kumar, MD, Raphael Fraser, PhD, Noel Estrada-Merly, MS, Maxim Norkin, MD PhD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Anita D'Souza, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-139017
Published: 2020
Journal Articles

Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant

Christopher Lemieux, MD, Lori S. Muffly, MD MS, Sally Arai, MD MS, Andrew R. Rezvani, MD, Surbhi Sidana, MD, Laura J. Johnston, MD, Wen-Kai Weng, MD PhD, Parveen Shiraz, MD, Matthew J. Frank, MD PhD, Everett H Meyer, MD PhD, Judith A Shizuru, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Robert Lowsky, MD FRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-134250
Published: 2020
Journal Articles

Long-Term Outcomes of Patients with Peripheral T-Cell Lymphoma after Autologous Hematopoietic Cell Transplantation

Olivier Veilleux, MD, Francisco Socola, MD, Sally Arai, MD MS, Robert Lowsky, MD FRCP, Judith A Shizuru, MD PhD, Parveen Shiraz, MD, Lori S. Muffly, MD MS, Laura J. Johnston, MD, Matthew J. Frank, MD PhD, Surbhi Sidana, MD, Everett H Meyer, MD PhD, Andrew R. Rezvani, MD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Wen-Kai Weng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-136493
Published: 2020
Journal Articles

CD22-Directed CAR T-Cell Therapy Mediates Durable Complete Responses in Adults with Relapsed or Refractory Large B-Cell Lymphoma after Failure of CD19-Directed CAR T-Cell Therapy and High Response Rates in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

John H. Baird, MD, Matthew J. Frank, MD PhD, Juliana Craig, BA, Shabnum Patel, PhD, Jay Y. Spiegel, MDFRCPC, Bita Sahaf, PhD, Sheren F. Younes, MD PhD, Jean S. Oak, MD PhD, Yasodha Natkunam, MD PhD, Zachary Ehlinger, MS, Warren D. Reynolds, BS, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Parveen Shiraz, MD, Surbhi Sidana, MD, Wen-Kai Weng, MD PhD, Liora M. Schultz, MD, Sneha Ramakrishna, MD, Kara L Davis, DO, Steven A. Feldman, PhD, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Lori S. Muffly, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-139087
Published: 2020
Journal Articles

Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma

Christopher Lemieux, MD, Juliana Craig, BA, David Iberri, MD, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Lori S. Muffly, MD MS, Parveen Shiraz, MD, Michaela Liedtke, MD, Andrew R. Rezvani, MD, Matthew J. Frank, MD PhD, Wen-Kai Weng, MD PhD, Everett H Meyer, MD PhD, Judith A Shizuru, MD PhD, Robert S. Negrin, MD, David B. Miklos, MD PhD, Surbhi Sidana, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-137091
Published: 2020
Journal Articles

Bleeding and Thrombosis Are Associated with Endothelial Dysfunction in CAR-T Cell Therapy and Are Increased in Patients Experiencing Neurologic Toxicity

Andrew Johnsrud, MD, Juliana Craig, BA, John H. Baird, MD, Jay Y. Spiegel, MDFRCPC, Lori S. Muffly, MD MS, James Zehnder, MD, Robert S. Negrin, MD, Laura J. Johnston, MD, Sally Arai, MD MS, Judith A Shizuru, MD PhD, Robert Lowsky, MD FRCP, Everett H Meyer, MD PhD, Wen-Kai Weng, MD PhD, Parveen Shiraz, MD, Andrew R. Rezvani, MD, Theresa Latchford, RN, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Matthew J. Frank, MD PhD, Surbhi Sidana, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-142218
Published: 2020
Journal Articles

Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis

Surbhi Sidana, MD, Surendra Dasari, PhD, Taxiarchis Kourelis, MD, Angela Dispenzieri, MD, David L Murray, MD PhD, Rebecca L. King, MD, Ellen D. McPhail, MD, Marina Ramirez-Alvarado, Shaji K. Kumar, MD, Morie A. Gertz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1770.
https://doi.org/10.1182/blood-2019-121714
Published: 2019
Journal Articles

Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease

Surbhi Sidana, MD, David L Murray, MD PhD, Surendra Dasari, PhD, Ronald S. Go, MD, Maria Alice Willrich, PhD, Melissa Snyder, PhD, Mindy Kohlhagen, John A. Lust, MD PhD, Eli Muchtar, MD, Taxiarchis Kourelis, MD, Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3510.
https://doi.org/10.1182/blood-2019-121712
Published: 2019
Journal Articles

Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses

Alfred Chung, MD, Gregory P. Kaufman, MD, Surbhi Sidana, MD, David Iberri, MD, Erik Eckhert, MD MS, Stanley Schrier, MD, Richard Lafayette, MD, Sally Arai, MD, Ronald Witteles, MD, Michaela Liedtke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1884.
https://doi.org/10.1182/blood-2019-124981
Published: 2019
Journal Articles

Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis

Alfred Chung, MD, Gregory P. Kaufman, MD, Surbhi Sidana, MD, Erik Eckhert, MD MS, Stanley Schrier, MD, Sally Arai, MD, Richard Lafayette, MD, Ronald Witteles, MD, Michaela Liedtke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1828.
https://doi.org/10.1182/blood-2019-122152
Published: 2019
Journal Articles

Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life

Surbhi Sidana, MD, Gita Thanarajasingam, MD, Joan Griffin, PhD, Carrie A. Thompson, MD, Michelle Burtis, Rahma Warsame, MD, Jonas Paludo, MD, Andrea Cheville, Morie A Gertz, MD, Angela Dispenzieri, MD, Jose Villasboas, MD, Stephen M Ansell, MD PhD, S. Vincent Rajkumar, MD, Kathleen J Yost, PhD, N. Nora Bennani, MD, Mustaqeem Siddiqui, MD, Yi Lin, MD PhD, Shaji K. Kumar, MD, Amylou C. Dueck, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 794.
https://doi.org/10.1182/blood-2019-121715
Published: 2019
Journal Articles

IgM Associated Light Chain (AL) Amyloidosis: Delineating Disease Biology with Clinical, Genomic and Bone Marrow Morphological Features

Surbhi Sidana, MD, Rebecca L King, MD, Patricia Greipp, DO, Angela Dispenzieri, MD, Rong He, MD, Nidhi Tandon, MD, Taxiarchis Kourelis, MD, David S. Viswanatha, MD, Eli Muchtar, MD, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Martha Q. Lacy, MD, Francis K. Buadi, MB, CHB, Suzanne R. Hayman, MD, Nelson Leung, MD, Robert A. Kyle, MD, Shaji K. Kumar, MD, Morie A. Gertz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4460.
https://doi.org/10.1182/blood-2018-99-117695
Published: 2018
Journal Articles

Prognostic Significance of Baseline High Risk Features during Follow-up in Immunoglobulin Light Chain Amyloidosis

Nidhi Tandon, MD, Surbhi Sidana, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD, Francis K Buadi, MD, Martha Q Lacy, MD, David Dingli, MD, Amie Fonder, PA-C, Suzanne R. Hayman, MD, Miriam Hobbs, CNP, Wilson I Gonsalves, MD, Yi L. Hwa, DNP, Prashant Kapoor, MD, Robert A Kyle, MD, Nelson Leung, MD, Ronald S. Go, MD, John A. Lust, MD PhD, Stephen J. Russell, MD PhD, S. Vincent Rajkumar, MD, Shaji K Kumar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5370.
https://doi.org/10.1182/blood.V130.Suppl_1.5370.5370
Published: 2017
Journal Articles

Prognostic Impact of Complete Response after First Line Therapy on Outcomes Following Initial Relapse in Newly Diagnosed Multiple Myeloma

Nidhi Tandon, MD, Surbhi Sidana, MD, S. Vincent Rajkumar, MD, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD, Rahma Warsame, MD, Taxiarchis Kourelis, MD, Martha Q Lacy, MD, David Dingli, MD, Amie Fonder, PA-C, Suzanne R. Hayman, MD, Miriam Hobbs, CNP, Yi L. Hwa, DNP, Francis K Buadi, MD, Robert A Kyle, MD, Nelson Leung, MD, Ronald S. Go, MD, John A. Lust, MD PhD, Stephen J. Russell, MD PhD, Shaji K Kumar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3030.
https://doi.org/10.1182/blood.V130.Suppl_1.3030.3030
Published: 2017
Journal Articles

Outcomes with Early Response to First Line Treatment in Patients with Newly Diagnosed Multiple Myeloma

Nidhi Tandon, MD, Surbhi Sidana, MD, S. Vincent Rajkumar, MD, Prashant Kapoor, MD, Wilson I Gonsalves, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD, Taxiarchis Kourelis, MD, Rahma Warsame, MD, Francis K Buadi, MD, Martha Q Lacy, MD, David Dingli, MD, Amie Fonder, PA-C, Suzanne R. Hayman, MD, Miriam Hobbs, CNP, Yi L. Hwa, DNP, Robert A Kyle, MD, Nelson Leung, MD, Ronald S. Go, MD, John A. Lust, MD PhD, Stephen J. Russell, MD PhD, Shaji K Kumar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3031.
https://doi.org/10.1182/blood.V130.Suppl_1.3031.3031
Published: 2017
Journal Articles

Composite Organ and Hematologic Response Model Risk Stratifies Patients with Light Chain Amyloidosis

Surbhi Sidana, MD, Nidhi Tandon, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD, Francis K Buadi, MD, Martha Q. Lacy, MD, David Dingli, MD PhD FRCP, Amie Fonder, PA-C, Suzanne R. Hayman, MD, Miriam Hobbs, CNP, Wilson I Gonsalves, MD, Yi L. Hwa, DNP, Prashant Kapoor, MD, Robert A. Kyle, MD, Nelson Leung, MD, Ronald S. Go, MD, John A Lust, MD PhD, Stephen J. Russell, MD PhD, Steven R. Zeldenrust, MD PhD, Moritz Binder, MDMPH, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3046.
https://doi.org/10.1182/blood.V130.Suppl_1.3046.3046
Published: 2017